Naprosyn and Sinemet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naprosyn (naproxen) and Sinemet (carbidopa; levodopa). Common drug interactions include oedema peripheral among females and depression among males.

The phase IV clinical study analyzes what interactions people have when they take Naprosyn and Sinemet. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Naprosyn?

Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 16,738 Naprosyn users. Check the latest studies of Naprosyn.

What is Sinemet?

Sinemet has active ingredients of carbidopa; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 29,601 Sinemet users. Check the latest studies of Sinemet.



On Jul, 27, 2026

87 people who take Naprosyn and Sinemet together, and have interactions are studied.

Naprosyn and Sinemet drug interactions.

What are the common drug interactions of Naprosyn and Sinemet, by gender? *:

female:

  1. Oedema peripheral (superficial swelling)
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Swelling
  4. Vision blurred
  5. Vomiting
  6. Weight decreased
  7. Bone disorder
  8. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  9. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  10. Fistula (an abnormal connection or passageway between two)

male:

  1. Depression
  2. Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
  3. Rash erythematous (redness of the skin)
  4. Pleural effusion (water on the lungs)
  5. Pyrexia (fever)
  6. Oedema peripheral (superficial swelling)
  7. Sweating increased (excess sweating)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Compulsions (performing an act persistently and repetitively)
  10. Drug intolerance (drug sensitivity)

What are the common drug interactions of Naprosyn and Sinemet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Vomiting
  2. Anxiety
  3. Depression
  4. Dyspnoea (difficult or laboured respiration)
  5. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Nausea (feeling of having an urge to vomit)
  8. Oedema peripheral (superficial swelling)
  9. Abdominal pain
  10. Antiphospholipid syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss)

50-59:

  1. Fall
  2. Fatigue (feeling of tiredness)
  3. Fistula (an abnormal connection or passageway between two)
  4. Gait disturbance
  5. Haematochezia (passage of stools containing blood)
  6. Headache (pain in head)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Joint sprain (an injury to joint surrounding flexible fibres)
  9. Muscular weakness (muscle weakness)
  10. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)

60+:

  1. Drug hypersensitivity
  2. Pneumonia
  3. Abdominal pain upper
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Anaemia (lack of blood)
  6. Arthralgia (joint pain)
  7. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  8. Depressed level of consciousness
  9. Duodenal ulcer
  10. Dyskinesia (abnormality or impairment of voluntary movement)

What are the existing conditions these people have? *

  1. High Blood Pressure: 18 people, 20.69%
  2. Constipation: 13 people, 14.94%
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints): 12 people, 13.79%
  4. Metastases To Bone (cancer spreads to bone): 11 people, 12.64%
  5. Breast Cancer: 11 people, 12.64%
  6. Bone Pain: 11 people, 12.64%
  7. Back Pain: 11 people, 12.64%
  8. Restless Leg Syndrome (a powerful urge to move your legs): 8 people, 9.20%
  9. Phobia Of Flying (fear of flying): 6 people, 6.90%
  10. Stress And Anxiety: 5 people, 5.75%

* Approximation only. Some reports may have incomplete information.

Do you take Naprosyn and Sinemet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Naprosyn and Sinemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Naprosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sinemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naprosyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sinemet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on naproxen and carbidopa; levodopa (the active ingredients of Naprosyn and Sinemet, respectively), and Naprosyn and Sinemet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: